Top Markets
Coin of the day
Algorae Pharmaceuticals Limited Algorae Pharmaceuticals Limited

Algorae Pharmaceuticals Limited

1AI
Rank in Stocks #30357
Algorae Pharmaceuticals Limited, a company established in 1987 and based in... Algorae Pharmaceuticals Limited, a company established in 1987 and based in Melbourne, Australia, focuses on pioneering pharmaceutical development. Known as Living Cell Technologies Limited until its rebranding in September 2023, the firm primarily conducts research and innovation in living cell technologies within New Zealand. Its development portfolio includes AI-116, a novel combination treatment pairing donepezil with cannabidiol, designed to address various forms of dementia, such as Alzheimer's disease. Another key candidate is AI-168, a unique blend of a cannabinoid and an existing, off-patent drug component, aimed at managing cardiovascular conditions like hypertension. Additionally, Algorae is progressing with NTCELL, an alginate-encapsulated product for the treatment of Parkinson's disease. The company is also collaborating with the University of New South Wales to create AlgaraeOS, an advanced drug discovery platform that utilizes artificial intelligence protocols and extensive data analytics to optimize drug identification and development processes.
Share Price
$0.00846342
Market Cap
$17.16M
Change (1 day)
9.09%
Change (1 year)
87.30%
Country
AU
Trade Algorae Pharmaceuticals Limited (1AI)

Category

Stock price history for Algorae Pharmaceuticals Limited (1AI)
Highest end of day price: $0.01 on 2026-08-01

Lowest end of day price: $0.01 on 2023-08-01
Stock price history of Algorae Pharmaceuticals Limited from 2023 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -10.71%
2025 104.60%
2024 -39.97%
2023 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$527.89 35.09%
US
$996.61 51.72%
NL
$114.49 -21.35%
AU
$735.86 6.07%
CH
$1.06K -6.13%
KR